Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial.
Ontology highlight
ABSTRACT: Serum Proteomic Analysis of patients with Hidradenitis Suppurativa treated with Fostamatinib
ORGANISM(S): Homo sapiens
PROVIDER: GSE240607 | GEO | 2023/08/10
REPOSITORIES: GEO
ACCESS DATA